HICKSVILLE, NY--(Marketwired - Aug 29, 2017) - Canbiola, Inc. (
"I am very honored and excited to join Canbiola's Medical Advisory Board. There are many different product options in this multi-billion-dollar CBD industry and the feedback from my patients, as well as my very extensive evaluation, has led me to believe Canbiola's CBD products are absolutely the best choice on the market today. Canbiola has non-GMO ingredients, the highest level of CBD out there, and other offerings which will include their proprietary Nano technology that I feel will make Canbiola a leader in the CBD industry. I will be distributing their products to my patients, because patient care is my primary purpose, it has been for 37 years and will continue to be," Dr. Harry Benisatto stated.
"We have been rapidly executing on our plan to strengthen not only our Medical Advisory Board but also our distribution network and, with the addition of Dr. Benisatto, we accomplish both," says Marco Alfonsi, Canbiola CEO who continues, "we expect to continually add to our Medical Advisory Board and distributing doctors."
About Dr. Harry Benisatto, D.C. / Medical Advisor
Dr. Benisatto is the director and owner of The Port Washington Nutrition and Weight Loss Center. He uses a holistic approach to patient care, including nutritional counseling and physical medicine modalities. Dr. Benisatto believes that many metabolic and inflammatory processes in our body can be treated using a holistic approach. Tailored supplementation and physical medicine can also be used as an adjunct to traditional medicine in many cases.
Board Certifications, Affiliations and Training:
* Research internship in infrared thermography York Chiropractic College Outpatient Facility, Levittown, New York * Active practice since July, 1981 * Board Certified by the National Board of Chiropractic Examiners * Board Certified in Electromyography and Electro-diagnostics * Board Certified in Manipulation Under Anesthesia * Member of the New York Chiropractic Council * Past Member of the Winthrop Hospital Chiropractic Collaborative program * Extensive post graduate studies in nutrition and wellness * Post graduate studies in "Botanical Therapies in Chiropractic Practice" * Post graduate studies in "Advanced Nutrition Principles, Nutritional Interventions, and Nutraceutical Applications in Clinical Practice"
About Canbiola, Inc.
Canbiola, Inc . is a public company trading under symbol CANB . The company's focus is in the sale of a variety of Cannabidiol (CBD) based products derived from legally imported Hemp. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. The company has already launched several products found at www.canbiola.com . Cannabis is currently federally illegal and has been legalized for medical purposes in varying forms in only a limited number of states.
The company also owns two technological solutions, "Wrapmail" (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, and "Prosperity Systems" and the "Bullseye" platform of document management and compliance targeted at broker dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.
Forward looking statements and risks and uncertainties Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected results, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. We do not undertake to update any statement should actual result differ from the forward-looking statement.
For more complete information regarding our business at Canbiola . Twitter Facebook
CONTACT INFORMATION Canbiola Investor Relations IR@canbiola.com Phone (516) 595-9544 http://www.canbiola.com
